The latest news, trends, analysis, interviews and podcasts from the global food and beverage industry

Are GLP-1 drugs a genuine long-term disruption or simply the latest health hype cycle? And with uptake rising fast, what does this mean for the future of F&B and how should the industry respond?

Vitafoods Europe's Francesca Berry explores how the focus is turning toward food quality over quantity – with new approaches to gut health and carbs under the spotlight.

Co-op has announced the launch of its own-brand range of GLP-1 friendly ready meals as part of a new health initiative dubbed 'Good Fuel'.

As appetite-suppressing GLP-1 medications gain traction, new research from Cornell University suggests measurable shifts in food purchasing are emerging.

As GLP-1 drugs go mainstream, Jess Ryall explores how appetite suppression is reshaping snacking, innovation, and brand trust.

Nestlé Health Science has announced a new partnership with Australia Catholic University to accelerate start-up innovation through its incubator programme in women’s health, longevity and weight management.

FMCG manufacturer and supplier Supreme has acquired the trade and selected UK and European assets of SlimFast from Glanbia in a £20 million deal, announced today.

Tom Ellis, CEO and co-owner at Brand Genetics, explains how the latest surge of weight-loss drugs is disrupting consumption and what’s next for producers.

In a move to enhance its offerings in the health and wellness sector, Heartland Food Products Group has acquired the SlimFast US brand from Glanbia.